ecrin-mdr-crcClinical2011Adenocarcinoma of colonOncologic patientsOncologic PatientsAdenocarcinoma Of ColonInterventionalhttps://newmdr.ecrin.org/Study/2528540Italy7ELOXATIN*INFUS 1FL 40ML 5MG/MLAVASTIN*INFUS 1FL 400MG 16MLFLUOROURACILE TEVA*IV 5G 100MLLEDERFOLIN*INFUS 1FL 100MGXELODA*120CPR RIV 500MGECRIN MDROngoingfalseBevacizumab + Folfox4 or Xelox2 as first- line treatment in colorectal cancer. Randomized phase II study.Primary objectives: To estimate the effectiveness of the combination of Oxaliplatino and Capecitabine (XELOX-2) + bevacizumab measured in terms of objective response rate in non treaty advanced colorectal cancer treatment.2011-07-1525285402010-022091-31